BioHealth News Archive
Daniels: Johns Hopkins making ‘tremendous strides’ toward shared goals – Hub
Almost four years after the launch of the Ten by Twenty vision plan, Johns Hopkins University President Ronald J. Daniels today invited the university…
Read MoreMachine learning predicts the look of stem cells – Nature News & Comment
No two stem cells are identical, even if they are genetic clones. This stunning diversity is revealed today in an enormous publicly available online…
Read MoreD.C.-area venture capital funding off to a great start in 2017. Here’s what Pitchbook says companies raised in VC so far. – Washington Business Journal
Big funding deals across a number of industries propelled the D.C. area to one of its best first quarters in recent venture capital memory,…
Read MoreRegister for Health Datapalooza 2017 by this Friday, April 7 for Early Bird
April 27-28, 2017 - Washington, DC Secure your spot today at the 8th Annual Health Datapalooza, the gathering place for people and organizations creating…
Read MoreHow the Trump Administration Can Unshackle Innovation in Agricultural Biotechnology – ITIF
New techniques for improving plants and animals promise to reshape virtually every aspect of the relationship between humans and our environment for the better.…
Read MoreNCI to Build New Research Lab on JHU Montgomery County Campus – News – Johns Hopkins University Montgomery County Campus
The National Cancer Institute has picked the Johns Hopkins Montgomery County Campus as the site for a new laboratory building for its epidemiology and…
Read MoreFledgling biotech Vtesse in $200M buyout from struggling Sucampo – FierceBiotech
Despite only coming into life two years ago, Pfizer and NEA-backed upstart Vtesse has already seen its rare disease candidate VTS-270, for Niemann-Pick disease…
Read MoreTagrisso Gains Regular FDA Approval for NSCLC – MPR
The Food and Drug Administration (FDA) has approved Tagrisso (osimertinib; AstraZeneca) for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell…
Read MoreSilver Spring-based United Therapeutics Corp. (NASDAQ: UTHR) loses rules in challenge against drug patent – Washington Business Journal
Silver Spring-based biotech United Therapeutics Corp. (NASDAQ: UTHR) lost a recent challenge to one of its lead patents for its flagship drugs. The U.S.…
Read MoreHHS secretary proposes cutting reimbursements that fund university-based research
When President Trump proposed a cut of nearly 20 percent in support for the National Institutes of Health, many wondered how the administration would even…
Read MoreQiagen Exclusively Licenses AR-V7 Detection Method From Johns Hopkins – GenomeWeb
Qiagen said Friday after the close of the market that it has acquired an exclusive worldwide license from Johns Hopkins University for detection of…
Read MoreCanopy Biosciences Acquires Rights to New Johns Hopkins, WUSTL Gene-Editing Tech – GenomeWeb
Research tools developer Canopy Biosciences announced today that it has exclusively licensed a novel gene-editing technology from Washington University in St. Louis and Johns…
Read MoreIndependence’s digital health partnership provides seed capital to first company – IBX Newsroom
Independence Health Group, Ben Franklin Technology Partners of Southeastern Pennsylvania, and Safeguard Scientifics, Inc. have given a $150,000 seed investment to VitalTrax. This is…
Read MoreThe applied value of public investments in biomedical research – Science
Scientists and policy-makers have long argued that public investments in science have practical applications. Using data on patents linked to U.S. National Institutes of…
Read MoreThis Johns Hopkins startup has a new way to regrow soft tissue – Technical.ly Baltimore
Doctors can rebuild parts of the body that have been damaged, but they need soft tissue to do it. Whether it’s facial reconstruction after…
Read More